0 Comments
Medical holography has been breaking new frontiers in the medical holography industry which is significantly expanding the market. Market Research Future which concentrates on market reports linked to medical device sector amongst others recently made available a report on this sector. The industry for medical holography will develop very swiftly at a CAGR rate of 32%.
Increasing demand for precision and real time scanning and imaging products especially in medical setups has been a driving factor for the growth of Medical Holography Market As the current imaging techniques are not sufficient for gauging the extent of the illness or injuries especially in complex cases where the mortality rate is higher. Development of this market is being promoted due to its ability to increase the extent of applications for the sector. Industry Segments The division of the market is carried out on the basis of medical applications and the type. On the basis of the category of type the segment includes transmission hologram, reflection hologram and hybrid hologram. The medical application category comprises of X-ray holography, multiplexed holography for medical tomography, holography in dentistry, endoscopic holography, holography in ophthalmology, holographic light-in-flight recording method, and holography in orthopedic. The segment for ophthalmology has sub-segments which comprise of diffractive bifocal intraocular lens. Similarly the endoscopic holography further have sub-divisions like external hologram recording endoscope and internal hologram recording endoscope. Detailed Regional Analysis The industry for medical holography is divided into geographic regions such as Asia-Pacific, Americas, Europe, Middle East and Africa. The American region accounts for the largest market share for hologram machines because the early acceptance of new technologies and increased R&D which is being carried out in this region. The European region has the second main market for hologram machines. The Asia-Pacific region is seeing swift growth because of the rising factors such as improving healthcare infrastructure in developing economies such as China, India, and South Korea, healthcare spending, and growing consciousness regarding the use of holography products in medical use. The Middle Eastern and African region is developing gradually because of the slow rising economic growth and slow progress in the technological advancements. Global Competitive Analysis The rewarding scenarios accessible in this market are being utilized by candidates who are trying to extend their market coverage by centered development which will prove to be perfect for the growth of this industry sector. The companies in this industry space are connecting their resources to achieve their vision for achieving a considerable portion of the business as early as possible. The products that are on offer presently vary greatly due to the reason of the strong pace of technological discoveries. This has raised the chances for the approaching growth period. This consequence is productive for firms so that they may maintain fiscal liquidity to take the best conclusions in terms of strategy execution and planning. Few of the local and global players are involved in the medical holography industry are Eon Reality (US), Real View Imaging (Isarel), Echo Pixel (CA), Integraf (USA), Royal Philips (Netherland) and Nano live SA (Switzerland) READ FULL REPORT @https://www.marketresearchfuture.com/reports/medical-holography-market-1519 Related reports Pharmaceutical Excipients Market Digestible Sensors Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: www.marketresearchfuture.com Market Research Future (MRFR) has launched a new release on the Prostate Cancer Market Research Report – Global Forecast till 2025. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period.
The global prostate cancer market size was valued at USD 10 billion in 2018 and is expected to exhibit a strong 7.1% CAGR over the forecast period between 2018 and 2025, according to the latest research report from Market Research Future (MRFR). The global prostate cancer market is expected to be driven mostly by the growing awareness about prostate cancer and the increasing entry of effective prostate cancer medication, according to MRFR. Segmentation: The global prostate cancer market is segmented on the basis of treatment, end user, and region. By treatment, the global prostate cancer market is segmented into surgery and medication. The medication segment is further sub-segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, monoclonal antibodies, and others. By end use, the global prostate cancer market is segmented into hospitals and specialty centers. Regional Analysis: The Americas is the largest regional market for prostate cancer, followed by Europe. The widespread awareness about prostate cancer in North America has been a vital driver for the global prostate cancer market. According to the American Cancer Society, prostate cancer is the most common type of cancer among American men, and over 160,000 new cases were registered in 2018. The high geriatric population in North America and Europe is also a major driver for the global prostate cancer market. Prostate Cancer Market – Competitive Landscape Highly competitive, the prostate cancer market appears to be fragmented due to the presence of several notable players. To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Besides, the growing competition in the market is encouraging multinational companies to acquire small yet promising companies operating in the developing markets. Get Global Prostate Cancer Research Report: Information by Treatment [Medication (Chemotherapy, Monoclonal Antibodies, Targeted Therapy, Immunotherapy and Hormone Therapy) and Surgery], End User (Hospitals & Clinics, Ambulatory Surgical Centres, Specialty Centres, Others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 @ https://www.marketresearchfuture.com /reports/prostate-cancer-market-1580 Major Players Players leading the global prostate cancer market include Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US), OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals Inc., and Tokai Pharmaceuticals, Inc., among others. Latest Trending Reports Cancer Diagnostics Market Neurorehabilitation Devices Market About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com Market Research Future (MRFR) has launched a new release on the Prostate Cancer Market Research Report – Global Forecast till 2025. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period. The global prostate cancer market size was valued at USD 10 billion in 2018 and is expected to exhibit a strong 7.1% CAGR over the forecast period between 2018 and 2025, according to the latest research report from Market Research Future (MRFR). The global prostate cancer market is expected to be driven mostly by the growing awareness about prostate cancer and the increasing entry of effective prostate cancer medication, according to MRFR. Segmentation: The global prostate cancer market is segmented on the basis of treatment, end user, and region. By treatment, the global prostate cancer market is segmented into surgery and medication. The medication segment is further sub-segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, monoclonal antibodies, and others. By end use, the global prostate cancer market is segmented into hospitals and specialty centers. Regional Analysis: The Americas is the largest regional market for prostate cancer, followed by Europe. The widespread awareness about prostate cancer in North America has been a vital driver for the global prostate cancer market. According to the American Cancer Society, prostate cancer is the most common type of cancer among American men, and over 160,000 new cases were registered in 2018. The high geriatric population in North America and Europe is also a major driver for the global prostate cancer market. Prostate Cancer Market – Competitive Landscape Highly competitive, the prostate cancer market appears to be fragmented due to the presence of several notable players. To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Besides, the growing competition in the market is encouraging multinational companies to acquire small yet promising companies operating in the developing markets. Get Global Prostate Cancer Research Report: Information by Treatment [Medication (Chemotherapy, Monoclonal Antibodies, Targeted Therapy, Immunotherapy and Hormone Therapy) and Surgery], End User (Hospitals & Clinics, Ambulatory Surgical Centres, Specialty Centres, Others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 @ https://www.marketresearchfuture.com /reports/prostate-cancer-market-1580 Major Players Players leading the global prostate cancer market include Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US), OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals Inc., and Tokai Pharmaceuticals, Inc., among others. Latest Trending Reports Cancer Diagnostics Market Neurorehabilitation Devices Market About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.co Rheumatoid Arthritis Market Analysis, Guidelines Overview and Upcoming Trends Forecast to 20223/31/2020 Global Rheumatoid arthritis market Information, by drug type (Nonsteroidal anti-inflammatory drug type (NSAID), Steroids, Biologic agents) by diagnosis (C-Reactive Protein (CRP) Test, CCP, ESR test) by treatment (Synovectomy, Tendon repair, Joint fusion) - Forecast to 2022
Market Research Future published a research report on Global Rheumatoid Arthritis Market Research Report- Forecast To 2022. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions. Overview: According to the report published by Market Research Future (MRFR), the global rheumatoid arthritis market can expect robust growth during the forecast period (2016-2022). Rheumatoid arthritis is an autoimmune disorder that makes joints its primary targets. The joints get swollen, warm, and the disease makes it painful. The probability of joints from both sides getting affected is alarmingly high, like if the wrist gets affected on the left first, then a chance of the right becoming prone to the disease is relatively higher. Segmentation: MRFR’s report on the global rheumatoid arthritis market has been segmented by drug type, diagnosis, and treatment. Based on the drug type, the rheumatoid market can be segmented into steroids, non-steroidal anti-inflammatory drug type (NSAID), and disease-modifying anti-rheumatic drug type (DMARDs) and biologic agents. On the basis of treatment, the rheumatoid market includes synovectomy, tendon repair, joint fusion, and total joint replacement. Based on the diagnosis, the rheumatoid arthritis market includes C - reactive protein (CRP) test, CCP, ESR (Erythrocyte Sedimentation Rate) test, and synovial fluid analysis. Regional Segmentation : Rheumatoid Arthritis Market The regional segmentation of the global rheumatoid arthritis market segments the market into regional markets namely North America, Europe, Asia Pacific, and the Middle East & Africa. North America is the biggest market due to advanced medical facilities being available here, and it is expected to grow during the forecast period. The cream of this market comprises of the United States of America (USA) and Canada. Europe, the second largest market for rheumatoid arthritis is also expected to grow during the forecast period. After North America, Europe has maximum advanced medical facilities. Maximum revenue of this market comes from France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Europe. Global Rheumatoid arthritis market Information, by drug type (Nonsteroidal anti-inflammatory drug type (NSAID), Steroids, Biologic agents) by diagnosis (C-Reactive Protein (CRP) Test, CCP, ESR test) by treatment (Synovectomy, Tendon repair, Joint fusion) - Forecast to 2022 @ https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658 Competitive Landscape: These companies use strategies like merger, acquisition, marketing, branding, innovation, and other methods to stay abreast in the competitive market. Several companies like Pfizer Inc (U.S), AstraZeneca (U.K), Eli Lilly and company (U.S), F. Hoffmann-La Roche Ltd (Switzerland), Bristol-Myers Squibb Company (U.S), Novartis AG (Switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), and others are expected to make notable contributions. Browse Other Healthcare Related Reports Non-Invasive Monitoring Device Market Wearable Sensors Market About Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services Global Kyphosis Market Research Report: By Type (Postural Kyphosis, Scheuermann's Kyphosis, Congenital Kyphosis), Diagnostic Test & Diseases (X-ray, Biopsy, Aspirin, Ibuprofen, Naproxen, Spinal Fusion), End User (Hospitals, Diagnostic Centres, Research Organizations) - Forecast till 2025
OTIS Biotech Korea (Republic of Korea), Taeyeon Medical Co., Ltd (Republic of Korea), SURGI R&D (Republic of Korea), Medtronic, Depromed Inc. (Republic of Korea), BMKOREA (Republic of Korea), EC21 Inc. (Republic of Korea), and others are some of the leading players at the cutting edge of the competition in Kyphosis Market and are profiled in MRFR Analysis. Global Kyphosis Market - Overview Kyphosis is the condition in which back is exaggerated forward rounding owing to weakness in the spinal bones that crack or compress them. It can happen at any age but mostly genetic population get effected with kyphosis.This deformity can be caused by variety of problems such as osteoporosis, disk degeneration, birth defects, cancer in the spine, etc. The condition can also be caused by poor posture which can cause pain and breathing difficulties. It is a medical condition marked by the rounding of the back, which is normal with aging. Kyphosis is estimated to occur at any age. But a majority of the patients belongs the geriatric population. The condition is often related with osteoporosis. The Kyphosis can by type is classified into postural kyphosis, scheuermann's kyphosis, congenital kyphosis, and others. Some of the common symptoms of the diseases are inclusive of back pain and stiffness of the back account 24% of the total population Global Kyphosis Market - Competitive Analysis There are numerous players operating in the kyphosis market globally such as OTIS Biotech Korea (Republic of Korea), Taeyeon Medical Co., Ltd (Republic of Korea), SURGI R&D (Republic of Korea), Medtronic, Depromed Inc. (Republic of Korea), BMKOREA (Republic of Korea), EC21 Inc. (Republic of Korea) and others. Also, players are increasingly expanding their involvement in the developing region, making it difficult for regional vendors to compete with them, especially in terms of features such as portfolios, quality, and pricing. Most of the players involve in collaboration, acquisition, expansion, product launch, and partnership to lead the market and to maintain their market position. Global Kyphosis Market - Regional Analysis On regional basis, Global Kyphosis Market is segmented into four major regions namely Americas, Europe, Asia Pacific and the Middle East and Africa. Americas leads the Global Kyphosis Market owing the presence of well-developed economies like U.S. and Canada and a well-developed healthcare sector. Europe accounts for the second largest Global Kyphosis Market. Asia Pacific is estimated to be the fastest growing market. Japan and Australia are the major contributor for the market. Moreover, the presence of the developing economies like India have the have opportunities for the market growth. Middle East & Africa accounts the lowest share in the market due to presence of poor economies and present political conditions. Saudi Arabia, UAE, and Kuwait are the major contributor for the market growth in the Middle East & Africa. Get full report @https://www.marketresearchfuture.com/reports/kyphosis-market-1760 Related reports hematuria treatment market size Wearable Sensors Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services Leprosy Treatment Market– Overview
Leprosy is one of the diseases that had transformed societies following its outbreak, but after major efforts to eradicate this disease, the detection rates have fallen immensely. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The Leprosy Treatment Marketis expected to achieve $ 3.5 billion while progressing at a CAGR of 3.2 % through the forecast period. The stigma related to the disease had caused significant hurdles in the treatment of leprosy, but a better awareness of the symptoms of the disease has led to the development of the market. Improved detection techniques are expected to further aid the development of the market in the forecast period. Leprosy Treatment Market – Key Players: The competitors shaping the leprosy treatment market are – Systopic Laboratories Pvt. Ltd. Cadila Pharmaceuticals Novartis International AG Acme Pharmaceuticals Macleods Pharmaceuticals Glaxo SmithKline Astra Zeneca Lark Laboratories Ltd. ` Segmental Analysis The leprosy treatment market is segmented on the basis of disease type, drug class, and market channel. On the basis of drug class, the leprosy treatment market has been segmented into phenazine, sulfone, derivative, anti-tubercular drugs and others. On the basis of disease type, the market has been segmented into multibacillary leprosy and paucibacillary leprosy. On the basis of end users, the market has been segmented into contract, private, and others. The regions included in the market segmentation are Middle East, North America, Asia Pacific, Europe, Africa and the rest of the world. Detailed Regional Analysis The regional analysis of the leprosy treatment market covers regions such as the Middle East, North America, Asia Pacific, Europe, Africa and rest of the world. In the North American region, the US is responsible for the maximum market share owing to the favorable reimbursement scenario and increased expenditure on healthcare. The rapid market uptake of new technology in the US is also an essential driver of the market for leprosy treatment. The European region is the next biggest market owing to the availability of large disposable income and improving awareness. The Asia Pacific region is anticipated to have the most potential and it is expected to be led by nations such as China and India. The Middle East & Africa market is controlled by the Gulf nations especially Saudi Arabia and UAE. The poor regions of Africa are anticipated to witness restricted growth due to slow economic and political conditions and restricted healthcare penetration. Competitive Analysis The use of effective strategy execution techniques is expected to bear optimistically on the future growth of the Leprosy Treatment Market. The competitors in the market are attempting to establish various leaderships that will enable them to capture a more significant share of the market. Improved accessibility to diverse resources and capabilities is expected to impel the growth of the market in the coming forecast period. Moreover, the vertical integrations and product strategies of the market is increasing the prospects for the market players. The analysis of the market reveals that it is poised for a high growth rate in the forthcoming years. Product differentiation has created a favorable product differentiation scenario that is complementing the market’s growth. get full report @ https://www.marketresearchfuture.com/reports/leprosy-treatment-market-3862 Industry Updates Mar 2018 In a recent study by Flavio Alves Lara of the Oswaldo Cruz Institute and colleagues has for the first time characterized blood clots that help in detecting leprosy at an early stage. Their findings lead to a new understanding of how leprosy affects the circulatory system but also to possible new screening tests to detect leprosy sooner. Lara and colleagues had searched for blood clotting abnormalities among 638 leprosy patients and identified 35 patients who had uncommon fatty clots, which the researchers named “leprosum clots.” The team studied what factors could signal the development of these clots and what molecules were existing in them. Related Reports: Infusion Pump Market Halitosis Treatment Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: https://www.marketresearchfuture.com Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) — Global Forecast from 2017 to 2023
Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017–2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old population complements this factor since the elderly populace is more prone to acquiring diseases such as arthritis and cataract which induces additional demand for laser therapy. Heightened demand for minimally-invasive and non-invasive procedures is a major drive behind the growth of the market. Consumers are highly inclined towards medical procedures which do not involve incisions and cuts. Additionally, laser therapy is extensively used in dermatology and cosmetology. Skyrocketing demand for aesthetics also encourages the growth of the global laser therapy market. Use of laser therapy in dentistry is also a key market influencer. On the contrary, the growth of the global laser therapy market might be impeded by high costs associated with laser therapy. Segmentation The global laser therapy market has been segmented based on type and application. By type, the global laser therapy market has been segmented into diode lasers, solid state lasers, gas lasers, dye lasers, and others. By application, the global laser therapy market has been segmented into surgery, dermatology and aesthetics, dental, and others. The surgery segment is further segmented into urology, ophthalmology, and others. Regional Analysis The Americas, Asia Pacific (APAC), Europe, and The Middle East & Africa (MEA) are the key markets for laser therapy. The Americas is at the forefront of the global laser therapy market. A robust healthcare sector, high expenditure on healthcare, and widespread prevalence of chronic diseases in the region spur the growth of the global laser therapy market. In addition, the regions propensity to incorporate new and advanced technologies in the healthcare sector acts as a plus for the growth of the market. Other factors boosting the growth of the Americas market include growth in a number of aged populace and the presence of key players in the region. Europe holds the second most significant share of the global laser therapy market. The region invests substantially in R&D activities which coupled with the availability of funds creates a conducive environment for the growth of the laser therapy market in Europe. A broad base of the patient population, well-developed healthcare sector, and high government support contribute to the growth of the market. APAC is the fastest growing market for laser therapy. Expanding patient pool, development of the healthcare sector in the developing countries of China and India present growth opportunities to the APAC market. Also, increased affordability due to rising disposable income, government endeavors towards the modernization of the healthcare sector are other boosting factors. The MEA market is likely to exhibit the least share of the global laser therapy market. Limited availability of healthcare facilities, lack of funds, and lack of awareness and dearth of skilled medical professionals constrain the growth of the market over the forecast period, especially in the Africa region. The Middle East accounts for the foremost share of the MEA market and is driven by high healthcare expenditure in the region. Access Report Details @ https://www.marketresearchfuture.com/reports/laser-therapy-market-3812 Competitive Landscape The key players in the global laser therapy market include Biolase Inc. (U.S.), Alma Lasers (Israel), Cutera (U.S.), IRIDEX Corp. (U.S.), Valeant (Canada), Coherent, Inc. (U.S.), and Angiodynamics, Inc. (U.S.). Industry Updates In December 2018, TRUMPF GmbH, a company involved in laser technology, announced the acquisition of Photonics GmbH from Philips. Through the acquisition, TRUMPF intends to expand its foothold in the growing markets in the photonics and digital products sectors. Related news Medical Tourism Market Immunoassay Analyzers Market Share About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact https://www.marketresearchfuture.com |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |